A descriptive single‐centre experience of the management and outcome of maternal alloantibodies in pregnancy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Transfusion Medicine

• Publication date

  2017-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/tme.12430PMID 28608631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study

  2014cited by this paper
• Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn

  2014cited by this paper
• Neonatal outcomes of pregnancies affected by haemolytic disease of the foetus and newborn and managed with intrauterine transfusion: a service evaluation.

  2013influential reference
• Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

  2012cited by this paper
• Revised birth centiles for weight, length and head circumference in the UK-WHO growth charts

  2011cited by this paper
• Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first‐trimester screening (CME)

  2011cited by this paper
• The Obstetric Hematology Manual: Red cell alloimmunization

  2010influential reference
• Red-cell alloimmunization

  2010cited by this paper
• Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation.

  2009cited by this paper
• Alloimmunization in pregnancy during the years 1992–2005 in the central west region of Sweden

  2008cited by this paper
• Effect of screening for red cell antibodies, other than anti‐D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands

  2008cited by this paper
• Guideline for blood grouping and antibody testing in pregnancy

  2007cited by this paper
• Update on HDFN: new information on long-standing controversies

  2006cited by this paper
• Birthweight in Haemolytic Disease of Newborn

  2006cited by this paper
• Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.

  2006cited by this paper
• Middle cerebral artery peak systolic velocity for the diagnosis of fetal anemia: the untold story

  2005cited by this paper
• Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization.

  2005cited by this paper
• Management of pregnancies with RhD alloimmunisation

  2005cited by this paper
• Chapter 18 – Hemolytic Disease of the Newborn

  2004cited by this paper
• Conventional management of maternal red cell alloimmunization compared with management by Doppler assessment of middle cerebral artery peak systolic velocity.

  2003cited by this paper
• Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn

  2003cited by this paper
• Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization.

  2001cited by this paper
• NONINVASIVE DIAGNOSIS BY DOPPLER ULTRASONOGRAPHY OF FETAL ANEMIA DUE TO MATERNAL RED-CELL ALLOIMMUNIZATION

  2000cited by this paper
• Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses.

  2000cited by this paper
• RhD haemolytic disease of the fetus and the newborn.

  2000cited by this paper
• Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study

  1999cited by this paper
• British Committee for Standards in Haematology, Blood Transfusion Task Force (Chairman

  1998cited by this paper
• RhD hemolytic disease of the newborn.

  1998cited by this paper
• Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme

  1997cited by this paper
• Female Alloimmunization With Antibodies Known to Cause Hemolytic Disease

  1997cited by this paper
• Changing trends in the management of red blood cell alloimmunization in pregnancy.

  1994cited by this paper
• EFFECT OF RHESUS HAEMOLYTIC DISEASE UPON BIRTHWEIGHT

  1973cited by this paper
• Birthweight in haemoyytic disease of newborn.

  1971cited by this paper
• Blood Transfusion in Obstetrics

  1964cited by this paper
• Haemolytic disease of the newborn.

  1953cited by this paper

• Microfluidic chip designs and their application for E antigen typing on red blood cells

  2025cites this paper
• Successful management of severe Kell alloimmunization in pregnancy with intravenous immune globulin.

  2024cites this paper
• Hemolytic disease of the fetus and newborn—a perspective of immunohematology

  2024cites this paper
• The development and evanescence of red blood cell antibodies after transfusion: A multi‐institutional prospective study in Japan

  2024cites this paper
• Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes

  2023cites this paper
• Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape

  2023cites this paper
• Perinatal Outcome of Pregnant Women with RhD Sensitization: A Five-Year Cross-Sectional Study at a Tertiary Care Hospital in Ethiopia.

  2023cites this paper
• Frequency of red blood cells antibodies in possible cases of hemolytic disease of the newborn laboratory evidenced at Hemopa

  2022cites this paper
• Frühe und schwer verlaufende hämolytische Erkrankung des Fetus und Neugeborenen

  2020influential citation
• Silent red blood cell autoantibodies: Are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process?

  2020cites this paper
• Phenotype frequencies of Rh (C, c, E, e), M, Mia and Kidd blood group systems among ethnic Thai blood donors from the north‐east of Thailand

  2019influential citation
• Hämolytische Erkrankung des Fetus und Neugeborenen

  2018cites this paper
• Efficacy of Antenatal Intravenous Immunoglobulin Treatment in Pregnancies at High Risk due to Alloimmunization to Red Blood Cells

  2018cites this paper
• Hämolytische Erkrankung des Fetus und Neugeborenen

  2018cites this paper
• HLA‐DRB1*09:01 allele is associated with anti‐E immunization in a Chinese population

  2018influential citation